Page 8 - Guy Goodwin News Today

The main psychoactive ingredient found in magic mushrooms can significantly reduce symptoms of difficult-to-tr

Clinical trial demonstrates positive results for therapeutic use of psilocybin.

For years, scientists have been looking ever more seriously at the therapeutic effect of psychedelics, which are not legal under US federal law. However,

For years, scientists have been looking ever more seriously at the therapeutic effect of psychedelics, which are not legal under US federal law. However, despite this renewed interest, large-scale studies…

A new study of patients with hard-to-treat depression found that psilocybin, the active component in "magic mushrooms," is capable of easing depression.

Psychedelics show promise in treating depression: study

The main psychoactive ingredient found in magic mushrooms can significantly reduce symptoms of difficult-to-treat depression, data from the largest clinical trial ever to test the keenly-watched compound has found.

A large trial suggests the hallucinogen in magic mushrooms could treat severe depression.

Patients took the psychedelic drug in a supervised medical setting in a session that lasted six to eight hours.

CMPS earnings call for the period ending September 30, 2022.